Gadolinium contrast agents for CNS imaging: current concepts and clinical evidence.
about
Future of the Renal Biopsy: Time to Change the Conventional Modality Using Nanotechnology.Gadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents-current status.Label-Free Microfluidic Manipulation of Particles and Cells in Magnetic Liquids.T1-Weighted Hypersignal in the Deep Cerebellar Nuclei After Repeated Administrations of Gadolinium-Based Contrast Agents in Healthy Rats: Difference Between Linear and Macrocyclic Agents.Low-dose gadobenate dimeglumine-enhanced MRI of the kidney for the differential diagnosis of localized renal lesions.Compensatory biliary and urinary excretion of gadobenate ion after administration of gadobenate dimeglumine (MultiHance(®)) in cases of impaired hepatic or renal function: a mechanism that may aid in the prevention of nephrogenic systemic fibrosis?Myocardial T1-mapping at 3T using saturation-recovery: reference values, precision and comparison with MOLLIEffects of gadolinium-based contrast agent concentrations (0.5 M or 1.0 M) on the diagnostic performance of magnetic resonance imaging examinations: systematic review of the literature.Multiparametric magnetic resonance imaging for transition zone prostate cancer: essential findings, limitations, and future directions.Survey of gadolinium-based contrast agent utilization among the members of the Society for Pediatric Radiology: a Quality and Safety Committee report.Interstudy repeatability of self-gated quantitative myocardial perfusion MRI.Are there differences between macrocyclic gadolinium contrast agents for brain tumor imaging? Results of a multicenter intraindividual crossover comparison of gadobutrol with gadoteridol (the TRUTH study).Deep Brain Nuclei T1 Shortening after Gadobenate Dimeglumine in Children: Influence of Radiation and Chemotherapy.The Benefits of High Relaxivity for Brain Tumor Imaging: Results of a Multicenter Intraindividual Crossover Comparison of Gadobenate Dimeglumine with Gadoterate Meglumine (The BENEFIT Study).Effectiveness of a high relaxivity contrast agent administered at half dose in dynamic susceptibility contrast MRI of brain gliomas.In vivo dentate nucleus MRI relaxometry correlates with previous administration of Gadolinium-based contrast agents.Diffuse myocardial fibrosis among healthy pediatric heart transplant recipients: Correlation of histology, cardiovascular magnetic resonance, and clinical phenotype.Macrocyclic paramagnetic agents for MRI: Determinants of relaxivity and strategies for their improvement.Nephrotoxicity of gadolinium-based contrast in the setting of renal artery intervention: retrospective analysis with 10-year follow-up
P2860
Q30360777-9553EC85-EE37-46E1-85EA-03DF087A1819Q31045014-2C8A28CE-006E-499B-A588-9BC04C8E852DQ33842143-C7371FC0-C954-4652-9E00-E69940F1CAD9Q35827906-B351228B-7CA3-4246-90BD-DBAB23B66BC5Q36285082-9233AA76-485D-40CC-A299-B3C670A363D5Q36295407-0EA37742-F149-4C41-8BE1-A6618F3F4FD3Q37422112-C747CD1B-9133-4F51-A25F-727479324C2AQ38526948-CFECC008-3092-48ED-92B1-5183907596BDQ38658408-93FA549D-368D-4CFF-A8A2-23611ACDA00EQ38747409-C5D8160B-0DD0-44AE-8561-400EB8D5611EQ40215659-6C3E3EC0-C629-43D6-B3F6-3908A875DA62Q46805155-946B0E56-0F62-433F-813C-BF6B287F5B7EQ47340326-F9D2E4FF-010F-4F3D-811F-53DCC21B7E1CQ48157270-192B75A6-BB3E-433F-A0B4-880E136DDB8BQ48177044-343A8BC6-BF9B-490D-9B60-EA9B0FC22F07Q48231937-65406040-8BBE-4178-90CF-3D07AA591C2AQ48337289-ACCBE936-E061-4FE5-B62B-55A4083AADDAQ48759394-735614C0-3D4E-4BCF-B12B-E9477DB4DEA0Q58549834-11824C1B-3C0A-40D6-90EE-614E5BA608BC
P2860
Gadolinium contrast agents for CNS imaging: current concepts and clinical evidence.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Gadolinium contrast agents for CNS imaging: current concepts and clinical evidence.
@en
type
label
Gadolinium contrast agents for CNS imaging: current concepts and clinical evidence.
@en
prefLabel
Gadolinium contrast agents for CNS imaging: current concepts and clinical evidence.
@en
P2093
P2860
P356
P1476
Gadolinium contrast agents for CNS imaging: current concepts and clinical evidence.
@en
P2093
P2860
P304
P356
10.3174/AJNR.A3917
P577
2014-05-22T00:00:00Z